OPUS POINT PARTNERS MANAGEMENT, LLC
Latest 13F filing data - Q3 2019
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | EXAS | 9K | $771.00K |
 | VRTX | 8K | $1.40M |
 | ASND | 6K | $596.00K |
 | FGEN | 6K | $212.00K |
 | RARE | 5K | $217.00K |
 | ILMN | 5K | $1.44M |
 | GILD | 4K | $259.00K |
 | UTHR | 3K | $279.00K |
 | MTD | 3K | $2.28M |
 | NBIX | 3K | $282.00K |
 | REGN | 2K | $677.00K |
 | LGND | 2K | $242.00K |
 | CRL | 2K | $280.00K |
 | IQV | 2K | $297.00K |
 | TECH | 2K | $303.00K |
 | AMGN | 2K | $294.00K |
 | BIIB | 1K | $261.00K |
Exact Sciences Corporation
EXAS
Shares Held
9K
Value
$771.00K
Vertex Pharmaceuticals Incorporated
VRTX
Shares Held
8K
Value
$1.40M
Ascendis Pharma A/S
ASND
Shares Held
6K
Value
$596.00K
FibroGen, Inc.
FGEN
Shares Held
6K
Value
$212.00K
Ultragenyx Pharmaceutical Inc.
RARE
Shares Held
5K
Value
$217.00K
Illumina, Inc.
ILMN
Shares Held
5K
Value
$1.44M
Gilead Sciences, Inc.
GILD
Shares Held
4K
Value
$259.00K
United Therapeutics Corporation
UTHR
Shares Held
3K
Value
$279.00K
Mettler-Toledo International Inc.
MTD
Shares Held
3K
Value
$2.28M
Neurocrine Biosciences, Inc.
NBIX
Shares Held
3K
Value
$282.00K
Regeneron Pharmaceuticals, Inc.
REGN
Shares Held
2K
Value
$677.00K
Ligand Pharmaceuticals Incorporated
LGND
Shares Held
2K
Value
$242.00K
Charles River Laboratories International, Inc.
CRL
Shares Held
2K
Value
$280.00K
IQVIA Holdings Inc.
IQV
Shares Held
2K
Value
$297.00K
Bio-Techne Corporation
TECH
Shares Held
2K
Value
$303.00K
Amgen Inc.
AMGN
Shares Held
2K
Value
$294.00K
Biogen Inc.
BIIB
Shares Held
1K
Value
$261.00K